• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular mechanisms of activated osteoblast-induced myeloma death through mitochondrial impairment and metabolic perturbation

Research Project

Project/Area Number 16K18420
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Tumor biology
Research InstitutionThe University of Tokushima

Principal Investigator

NAKAMURA Shingen  徳島大学, 大学院医歯薬学研究部(医学系), 助教 (10511321)

Project Period (FY) 2016-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywordsmultiple myeloma / osteoblast / Pim-2 / PGC-1α / AMPK / mature osteoblast / pim-2 / PGC-1 / 成熟骨芽細胞 / ミトコンドリア / がん抑制性ニッチ / 酸性環境
Outline of Final Research Achievements

In contrast to bone marrow stromal cells or osteoclasts, mature osteoblasts (OBs) induced myeloma (MM) cell death in parallel with downregulation of the pro-survival mediator Pim-2. The Pim-2 reduction triggered the downregulation of PGC-1α, an activator of glycolysis and mitochondrial biogenesis, along with subsequent ATP reduction and phosphorylation of AMPK, a key energy sensor, in MM cells. The AMPK inhibitor dorsomorphin mitigated MM cell death in cocultures with OBs. Therefore, the prompt reduction of Pim-2 and thereby PGC-1α suppression and AMPK activation in MM cells are suggested to cause the mature OB-triggered MM cell death with energy crisis.

Report

(3 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report

Research Products

(15 results)

All 2018 2017 2016

All Journal Article (9 results) (of which Peer Reviewed: 9 results,  Open Access: 3 results) Presentation (6 results) (of which Int'l Joint Research: 1 results)

  • [Journal Article] Effective impairment of myeloma cells and their progenitors by hyperthermia.2018

    • Author(s)
      Hirokazu Miki, Shingen Nakamura, Asuka Oda, Hirofumi Tenshin, Jumpei Teramachi, M. Hiasa, A. Bat-Erdene, Y. Maeda, M. Oura, M. Takahashi, M. Iwasa, T. Harada, S. Fujii, K. Kurahashi, S. Yoshida, K. Kagawa, I. Endo, K. Aihara, M. Ikuo, K. Itoh, Koichiro Hayashi, Michihiro Nakamura, Masahiro Abe
    • Journal Title

      Oncotarget.

      Volume: 9 Pages: 10307-10316

    • DOI

      10.18632/oncotarget.23121

    • NAID

      120006576960

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome2018

    • Author(s)
      Nakamura Shingen、Azuma Momoyo、Maruhashi Tomoko、Sogabe Kimiko、Sumitani Ryohei、Uemura Munenori、Iwasa Masami、Fujii Shiro、Miki Hirokazu、Kagawa Kumiko、Hiraga Takashi、Kondo Noriyasu、Fujita Hiromi、Mahara Fumihiko、Abe Masahiro
    • Journal Title

      Journal of Infection and Chemotherapy

      Volume: 24 Pages: 389-392

    • DOI

      10.1016/j.jiac.2017.11.004

    • NAID

      120006556288

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity.2018

    • Author(s)
      Fujii S, Nakamura S, Oda A, Miki H, Tenshin H, Teramachi J, Hiasa M, Bat-Erdene A, Maeda Y, Oura M, Takahashi M, Iwasa M, Endo I, Yoshida S, Aihara KI, Kurahashi K, Harada T, Kagawa K, Nakao M, Sano S, Abe M.
    • Journal Title

      Br J Haematol.

      Volume: 180(2) Pages: 246-258

    • DOI

      10.1111/bjh.15033

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects2017

    • Author(s)
      Tenshin Hirofumi、Teramachi Jumpei、Tanaka Eiji、Matsumoto Toshio、Abe Masahiro (他16人中2番目)
    • Journal Title

      Blood Adv.

      Volume: 1 Pages: 2124-2137

    • DOI

      10.1182/bloodadvances.2017008813

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Multiple myeloma with high adenosine deaminase expression2017

    • Author(s)
      Shingen NAKAMURA, Hirokazu MIKI, Masami IWASA, Akishige IKEGAME,Tomoko MARUHASHI, Ryohei SUMITANI, Munenori UEMURA, Mamiko TAKAHASHI,Asuka ODA, Shiro FUJII, Kumiko KAGAWA and Masahiro ABE
    • Journal Title

      International Journal of Myeloma

      Volume: 7 Pages: 1-5

    • NAID

      120006842039

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena Cava2017

    • Author(s)
      Nakamura S, Kagawa K, Sumitani R, Uemura M, Takahashi M, Iwasa M, Fujii S, Miki H, Abe M
    • Journal Title

      internal medicine

      Volume: 56 Pages: 2043-2047

    • NAID

      130005876447

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.2017

    • Author(s)
      Teramachi J, Hiasa M, Oda A, Harada T, Nakamura S, Amachi R, Tenshin H, Iwasa M, Fujii S, Kagawa K, Miki H, Kurahashi K, Yoshida S, Endo I, Haneji T, Matsumoto T, Abe M.
    • Journal Title

      Br J Haematol.

      Volume: 印刷中

    • NAID

      120006549655

    • Related Report
      2016 Research-status Report
    • Peer Reviewed
  • [Journal Article] Susceptibility to bendamustine considerably varies among myeloma cells, but is enhanced in acidic conditions2016

    • Author(s)
      Nakamura S, Miki H, Oda A, Amachi R, Teramachi J, Sogabe K, Fujino H, Maruhashi T, Fujii S, Kagawa K , Abe M
    • Journal Title

      International Journal of Myeloma.

      Volume: 6 Pages: 7-11

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.2016

    • Author(s)
      Amachi R, Hiasa M, Teramachi J, Harada T, Oda A, Nakamura S, Hanson D, Watanabe K, Fujii S, Miki H, Kagawa K, Iwasa M, Endo I, Kondo T, Yoshida S, Aihara KI, Kurahashi K, Kuroda Y, Horikawa H, Tanaka E, Matsumoto T, Abe M.
    • Journal Title

      Oncotarget.

      Volume: 7 Pages: 70447-70461

    • NAID

      120006576954

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Mature osteoblasts reduce Pim-2 to cause an energy crisis in myeloma cells2017

    • Author(s)
      Shingen Nakamura, Hirokazu Miki, Hirofumi Tenshin, Keiichiro Watanabe, Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Yusaku Maeda, Masahiro Oura, Mamiko Takahashi, Masami Iwasa, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Masahiro Abe
    • Organizer
      日本血液学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Mature osteoblasts reduce Pim-2 to cause an energy crisis in myeloma cells2017

    • Author(s)
      Shingen Nakamura, Hirokazu Miki, Hirofumi Tenshin, Keiichiro Watanabe, Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Yusaku Maeda, Masahiro Oura, Mamiko Takahashi, Masami Iwasa, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Masahiro Abe
    • Organizer
      日本骨髄腫学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Osteoblast creates a non-permissive niche for myeloma2017

    • Author(s)
      Ryota Amachi, Masahiro Hiasa , Jumpei Teramachi, Asuka Oda, Ariunzaya Bat-Erdene, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiro Fujii, Eiji Tanaka , Toshio Matsumoto , Masahiro Abe
    • Organizer
      IADR/AADR/CADR General Session & Exhibition
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Restoration of bone formation induces an energy crisis in myeloma cells2017

    • Author(s)
      Ryota Amachi, Shingen Nakamura, Hirokazu Miki, ,Hirofumi Tenshin, Keiichiro Watanabe, Jumpei Teramachi, Asuka Oda, Masami Iwasa, Shiro Fujii,Kumiko Kagawa, Masahiro Abe
    • Organizer
      日本骨髄腫学会2017
    • Place of Presentation
      日本赤十字看護大学 (東京都 渋谷区)
    • Related Report
      2016 Research-status Report
  • [Presentation] Alteration of Pim-2 synthesis and degradation in myeloma cells by anti-myeloma agents.2016

    • Author(s)
      Shingen Nakamura, Hirokazu Miki, Ariunzaya BAT-ERDENE,Hirofumi Tenshin, Ryota Amachi, Keiichiro Watanabe, Jumpei Teramachi, Asuka Oda, Masami Iwasa, Shiro Fujii,Kumiko Kagawa, Masahiro Abe
    • Organizer
      日本血液学会総会2016
    • Place of Presentation
      パシフィコ横浜(神奈川県 横浜市)
    • Year and Date
      2016-10-13
    • Related Report
      2016 Research-status Report
  • [Presentation] Creation of a non-permissive niche for myeloma by bone formation2016

    • Author(s)
      Ryota Amachi, Jumpei Teramachi,Masahiro Hiasa,Takeshi Harada,Asuka Oda,Shingen Nakamura,Keiichiro Watanabe,Shiro Fujii,Hirokazu Miki,Kumiko Kagawa,Itsuro Endo,Eiji Tanaka,Toshio Matsumoto,Masahiro Abe
    • Organizer
      日本血液学会総会2016
    • Place of Presentation
      パシフィコ横浜(神奈川県 横浜市)
    • Year and Date
      2016-10-13
    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi